Mullen Automotive (NASDAQ: MULN) is doing things differently in the EV and clean energy sector. Most people wouldn’t think that’s necessary, believing that all companies in the sector are committed to bringing clean energy solutions to consumers and industry in a responsible manner. Truth be told, that’s not always the case. Many in the sector
KULR Technology Group Inc. (NYSE: KULR) stock is a roller coaster ride of late. But with Wall Street analysts modeling for appreciably higher share prices, the motion sickness may be worth the interest. And with several updates showing KULR’s potentially dominant position in the thermal management and energy storage markets, paying less attention to index-created
Mainz Biomed (NASDAQ: MYNZ) stock gets pushed to degrees with low volume. But make no mistake, the trend in place is decidedly bullish. In fact, MYNZ stock has showed impressive performance in the worst of markets, decoupling from extraordinary small-cap biotech market weakness. Other day’s, MYNZ stock trades lower against a higher tape. So trying
A new generation of patients can be powerful motivators for a pharmaceutical industry historically resistant to change. And if they don’t respect or act on the message given, they should expect that plenty around them will. But here’s the deal. Some are doing more than listening; they are taking advantage of emerging research to capitalize
KULR Technology Group Inc. (NYSE: KULR) stock is undervalued. Or, better said, it’s disconnected from its fair value when appraising the value from its significant asset portfolio, well-protected IP, and contract visibility with some of the largest global conglomerates. And the KULR story isn’t just a forward-looking one. Recent operational performance has helped KULR score
Mainz Biomed (NASDAQ: MYNZ) may be doing a bit of a zig zag in recent trading but at the end of the day its stock has done something that few micro-cap biotech stocks have been able to match- trade higher. And with its decoupling putting a technical uptrend into motion, the best part of recent
If there is one thing to know about KULR Technology Group Inc. (NYSE: KULR), it’s this- they have positioned themselves to dominate the lithium-Ion battery safety market. And the better news; results from that work are showing, with revenues scoring record levels, costs decreasing, and expansion of its innovative technology into several high-volume, high-dollar markets.
KULR’s Milestones Reached Set Up A Potentially Powerful Q4 Rally ($KULR) Read More »
Mainz Biomed (NASDAQ: MYNZ) stock may present a value investment opportunity too good to ignore. In fact, a move higher is the likely path of least resistance for this thinly traded molecular genetics diagnostics company. They have a well-fortified balance sheet, best-in-class early cancer detection tests, and a management team that’s part of a Who’s
Smallcap stocks may be under pressure. But not all are being pulled down by the decidedly bearish sentiment. Cosmos Health (NASDAQ: COSM), formerly Cosmos Holdings, is decoupling from the weakness and is doing so on merit, not hype. In fact, its recent 28% surge to $0.46 in September is supported by another batch of excellent
Recharge Resources Ltd. (RR: CSE) (RECHF: OTC) (SL5: Frankfurt) is consolidating at multi-month highs, bumping against the $0.40 level, it’s highest point since April 2022. The move comes after a string of good news. Last week, Recharge announced receiving approval from Argentina’s Dept of Mines for its imminent drilling of a production diameter well at
